Analysis of the safety and efficacy of the currently marked oral anticoagulants was performed in patients after large joints arthroplasty. A total of 5025 patients after total knee arthroplasty and 5216 patients after...Analysis of the safety and efficacy of the currently marked oral anticoagulants was performed in patients after large joints arthroplasty. A total of 5025 patients after total knee arthroplasty and 5216 patients after total hip arthroplasty were examined. All patients were divided into groups by the prescribed anticoagulant. The duration of anticoagulant therapy was 35 days and 6 weeks after surgery, respectively. Ultrasonography of the lower extremities veins was performed in all patients prior to the surgery and 5 days after surgery. In patients receiving Dabigatran, the incidence of clinically significant deep vein thrombosis was lower compared with patients receiving Rivaroxaban and Apixaban; in contrast, the rate of postoperative hematomas in the last two groups was higher.展开更多
A contrast study on the effects of manual acupuncture and electroacupuncture wasconducted in 60 cases of chronic hepatitis B carriers.The results demonstrated that theimmunological functions,both cellular and humoral,...A contrast study on the effects of manual acupuncture and electroacupuncture wasconducted in 60 cases of chronic hepatitis B carriers.The results demonstrated that theimmunological functions,both cellular and humoral,were markedly regulated asevidenced by the negative turnover rates of HBsAg,HBeAg,anti-HBc and HBcAg,as wellas the positive turnover rate of anti-HBe.展开更多
Dear Editor,Since September 2012, the Middle East respiratory syndrome coronavirus (MERS-CoV) cases have been reported in more than 27 countries, and more than 2,000 cases have been confirmed in the laboratory (http:/...Dear Editor,Since September 2012, the Middle East respiratory syndrome coronavirus (MERS-CoV) cases have been reported in more than 27 countries, and more than 2,000 cases have been confirmed in the laboratory (http://www.who.int/emergencies/mers-cov/en/). MERS-CoV causes an acute and severe respiratory illness with a high mortality rate(~35%) in humans (Shi et al., 2017, Zaki et al., 2012).Neutralizing antibodies targeting the spike of MERS-CoV have been shown to be a therapeutic option for treatment of lethal disease (Agrawal et al., 2016, Ying et al., 2014).展开更多
文摘Analysis of the safety and efficacy of the currently marked oral anticoagulants was performed in patients after large joints arthroplasty. A total of 5025 patients after total knee arthroplasty and 5216 patients after total hip arthroplasty were examined. All patients were divided into groups by the prescribed anticoagulant. The duration of anticoagulant therapy was 35 days and 6 weeks after surgery, respectively. Ultrasonography of the lower extremities veins was performed in all patients prior to the surgery and 5 days after surgery. In patients receiving Dabigatran, the incidence of clinically significant deep vein thrombosis was lower compared with patients receiving Rivaroxaban and Apixaban; in contrast, the rate of postoperative hematomas in the last two groups was higher.
文摘A contrast study on the effects of manual acupuncture and electroacupuncture wasconducted in 60 cases of chronic hepatitis B carriers.The results demonstrated that theimmunological functions,both cellular and humoral,were markedly regulated asevidenced by the negative turnover rates of HBsAg,HBeAg,anti-HBc and HBcAg,as wellas the positive turnover rate of anti-HBe.
基金supported by the National Key Research and Development Program of China (2016YFD0500300 to Wenjie Tan)
文摘Dear Editor,Since September 2012, the Middle East respiratory syndrome coronavirus (MERS-CoV) cases have been reported in more than 27 countries, and more than 2,000 cases have been confirmed in the laboratory (http://www.who.int/emergencies/mers-cov/en/). MERS-CoV causes an acute and severe respiratory illness with a high mortality rate(~35%) in humans (Shi et al., 2017, Zaki et al., 2012).Neutralizing antibodies targeting the spike of MERS-CoV have been shown to be a therapeutic option for treatment of lethal disease (Agrawal et al., 2016, Ying et al., 2014).
